Craft

Novopyxis

Total Funding

$855.9 K

Novopyxis Summary

Company Summary

Overview
Novopyxis is a biotechnology company using mathematics and machine learning to engineer medical technology. Its flagship drug is both cardioprotective and neuroprotective, and can be used for the treatment of cardiomyopathy. The company also develops a device for medical dermatology applications.
Type
Private
Status
Active
Founded
2013
Website
http://www.novopyxis.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu